About Prilenia
Prilenia Therapeutics, a clinical-stage biotech company focused on the urgent mission of developing novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, is looking for a VP, Financeto join its team in the US.
We are a flexible, fast-moving team that is quickly advancing a potential therapy poised to have major impact on the lives of patients and their families. Our lead product candidate, pridopidine, holds Orphan Drug Designation in both Huntington’s disease (HD) and Amyotrophic lateral Sclerosis (ALS) in the U.S. and EU, as well as Fast Track designation from the FDA for the treatment of HD. Prileniarecently filed for regulatory approval in Europe for HD and expects to initiate a global phase 3 in ALS in early 2025. Prilenia also believes pridopidine’s novel mechanism of action as a Sigma-1 receptor agonist gives it potential in numerous other neurological diseases.
About the role
We are expanding our Finance team and are looking to add a Vice President, Finance as we prepare for potential commercialization of our lead product candidate, pridopidine. The ideal candidate will be a proactive and collaborative leader, with background in late-stage biotech/pharma(preferablywith commercial experience).
The Vice President, Finance will report to the Chief Financial Officer and will directly manage the global accounting and finance function. This position will have responsibility for general accounting, future SEC reporting, technical accounting, tax and tax planning, accounts payable, payroll, purchasing, equity administration, and financial analysis. This hands-on leadership role requires a candidate who can seamlessly navigate high-level, complex finance responsibilities while also delving into day-to-day details. As we are a virtual and global organization, we value candidates who are comfortable and adept in a remote work environment.
Reporting directly to the Chief Financial Officer, you will play a key role in steering our financial strategies and ensuring the success of our financial operations.
Improving the lives of patients and their families, by developing treatments for neurodegenerative and neurodevelopmental disorders, lies at the heart of Prilenia’s mission. We are a clinical stage biotech startup, led by Michael Hayden, MD, PhD....
2 jobsSubscribe to Rise newsletter